FDA’s device center is reworking its controversial draft 510(k) modifications guidance with the intent to issue a revised draft before finalizing a new policy.
CDRH Director Jeffrey Shuren signaled the plans during an April 18 user fee reauthorization hearing before the House Energy & Commerce Health Subcommittee. Republicans on the subcommittee, citing widespread complaints...